Innovation in Medical Cannabis: Data + Technology


Entrepreneurs in the industry are delivering products with cutting-edge innovation and formulators are developing products with high-level science. Marketing demand in the cannabis industry is driving innovation.  In May 2019, CannabizMD hosted the in-person event “Cannabis + Innovation”. That year, the global cannabis industry had a revenue of USD $15B. Three years later, dozens more U.S. states have established a medical program with18 states now have legalized adult use. Close to 70 countries across the globe have a CBD, medical cannabis, and/or adult use market. Prohibition Partners reports that combined global sales of CBD, medical, and adult-use cannabis topped USD $37.4 billion in 2021, and could rise to USD $102 billion by 2026.

CannabizMD Founder/CEO Jacquie Cohen Roth, MS, moderates a panel discussion focused on the innovation that’s been answering to this astounding market growth. She is joined by Andrea Baillo, PhD Matt Kamps, JD, MSJordan Medley, and Dr. Lola O Ohonba, PHARM.D. Topics of conversation include GMO cannabis; synthetic cannabinoids; the value of cannabis-centric patient data and water- soluble technology and cannabis infused beverages.

Innovation in Medical Cannabis: Data + Technology
Click through the photo to view the webinar recording. Visit and subscribe to the CannabizMD YouTube channel for more webinar recordings.
Previous articleSharon Bentley: Australian Medical Cannabis Industry Changemaker
Next articleInnovation or Danger: Hemp-Derived Cannabinoids + Delta-8 THC